SciBase Holding AB (publ)
STO:SCIB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
SciBase Holding AB (publ)
Total Liabilities
SciBase Holding AB (publ)
Total Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
SciBase Holding AB (publ)
STO:SCIB
|
Total Liabilities
kr45.5m
|
CAGR 3-Years
23%
|
CAGR 5-Years
30%
|
CAGR 10-Years
20%
|
|
|
Elekta AB (publ)
STO:EKTA B
|
Total Liabilities
kr19.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
CellaVision AB
STO:CEVI
|
Total Liabilities
kr207.3m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
19%
|
|
|
Getinge AB
STO:GETI B
|
Total Liabilities
kr27.1B
|
CAGR 3-Years
7%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Arjo AB (publ)
STO:ARJO B
|
Total Liabilities
kr7.5B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
S
|
Stille AB
STO:STIL
|
Total Liabilities
kr345.5m
|
CAGR 3-Years
31%
|
CAGR 5-Years
45%
|
CAGR 10-Years
33%
|
|
SciBase Holding AB (publ)
Glance View
SciBase Holding AB is a global medical technology company, which engages in the development and sale of instruments for the detection of skin cancer and other skin diseases. The company is headquartered in Sundbyberg, Stockholm and currently employs 23 full-time employees. The company went IPO on 2015-06-02. The firm specializes in the manufacture of point of care device, called Nevisense, which is aimed to detect of malignant melanoma. Nevisense analyze suspicious lesions by using Electrical Impedance Spectroscopy (EIS) which is applied as an electrical signal to the skin. The diagnostic product is sold in Nordic countries, Belgium, Germany, Great Britain and Australia.
See Also
What is SciBase Holding AB (publ)'s Total Liabilities?
Total Liabilities
45.5m
SEK
Based on the financial report for Dec 31, 2025, SciBase Holding AB (publ)'s Total Liabilities amounts to 45.5m SEK.
What is SciBase Holding AB (publ)'s Total Liabilities growth rate?
Total Liabilities CAGR 10Y
20%
Over the last year, the Total Liabilities growth was 81%. The average annual Total Liabilities growth rates for SciBase Holding AB (publ) have been 23% over the past three years , 30% over the past five years , and 20% over the past ten years .
